The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice insights from the prospective EARLY registry - Bramlage, Peter; Schmieder, Roland E.; Gitt, Anselm K.; Baumgart, Peter; Mahfoud, Felix; Buhck, Hartmut; Ouarrak, Taoufik; Ehmen, Martina; Potthoff, Sebastian A. (Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015)
Aus: Trials 16 (2015). <http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-1100-8>